Achillion Pharmaceuticals

INVESTORS

SEC Filings

 
SEC Filings
Date Filing Description View
May 24, 2017 8-K current report HTML PDF XLS
143.4 KB
May 8, 2017 DEFA14A definitive additional proxy materials HTML PDF
143.7 KB
May 4, 2017 8-K current report HTML PDF XLS
215.2 KB
May 4, 2017 10-Q quarterly report HTML PDF XLS XBRL
474.1 KB
Apr 17, 2017 DEF 14A definitive proxy statement HTML PDF XLS
603.2 KB
Feb 23, 2017 8-K current report HTML PDF XLS
218.6 KB
Feb 23, 2017 10-K annual report HTML PDF XLS XBRL
942.2 KB
Feb 23, 2017 S-3 registration statement HTML PDF XLS
386.7 KB
Feb 15, 2017 SC 13G/A amended statement of beneficial ownership HTML PDF XLS
137.3 KB
Feb 14, 2017 SC 13G/A amended statement of beneficial ownership HTML PDF XLS
129.4 KB
1
...
NextLast